TMO
TMO climbed 3.4 percent today after Thermo Fisher's proteomics platform identified more than 2,500 new biological associations in the PRECISE-SG100K study — a result that validates its position at the center of the next wave of drug discovery. That sounds academic. But here's the commercial translation: when your instruments generate landmark published findings, every pharma and biotech procurement team reads the paper and calls your rep. Proteomics — the large-scale study of proteins rather than genes — is where drug discovery is heading, and Thermo Fisher owns significant infrastructure in that pipeline. The custom recombinant proteins market it competes in is projected to reach 10 billion dollars by 2030, growing at 11 percent annually. Watch for institutional accumulation over the next few sessions to see whether this is conviction or noise.
-3.0% — Thermo Fisher Scientific (TMO): Strong Q3 Guidance and Broadening Demand Support Multi-Year Outlook
+3.4% — Thermo Fisher Scientific Proteomics Technologies Enable Discovery of More Than 2,500 New Biological Associatio
-3.3% — Cell and Gene Therapy Bio-Manufacturing Market Global Report 2026: Market to Surge to $21.46 Billion by 2030 a
+2.0% — Cell Isolation/Cell Separation Market Forecasts Growth from $6.97B (2026) to $13.51B by 2032, Profiling Thermo
+1.5% — Three Analysts, Three Verdicts on Thermo Fisher: Here’s Who the Numbers Favor
+4.5% — Thermo Fisher CEO Says AI Will Drive More Pharma Spending — Sees 7% Organic Growth By 2028
-1.8% — Research Use Recombinant Protein Market Report Now Available — Forecasts Market Growth from $1.11B (2026) to $
+1.6% — Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, Deere & Company, Dell Technologies, Devo
-2.7% — TMO Stock Could Gain Following the Launch of EMPAD G2 Detector
+2.3% — Moved with the tape — no single reported reason that day.
+4.2% — Moved with the tape — no single reported reason that day.
+2.4% — Moved with the tape — no single reported reason that day.
+2.3% — Moved with the tape — no single reported reason that day.
-1.6% — Moved with the tape — no single reported reason that day.
+3.0% — Moved with the tape — no single reported reason that day.
-1.5% — Moved with the tape — no single reported reason that day.
+8.7% — Moved with the tape — no single reported reason that day.
-2.0% — Moved with the tape — no single reported reason that day.
+2.9% — Moved with the tape — no single reported reason that day.
+2.0% — Moved with the tape — no single reported reason that day.
+2.4% — Moved with the tape — no single reported reason that day.
+2.8% — Moved with the tape — no single reported reason that day.
+4.9% — Moved with the tape — no single reported reason that day.
-2.3% — Moved with the tape — no single reported reason that day.
-2.4% — Moved with the tape — no single reported reason that day.
+5.2% — Moved with the tape — no single reported reason that day.
-1.9% — Moved with the tape — no single reported reason that day.
+1.7% — Moved with the tape — no single reported reason that day.
-1.7% — Moved with the tape — no single reported reason that day.
-2.4% — Moved with the tape — no single reported reason that day.
+6.8% — Moved with the tape — no single reported reason that day.
+1.8% — Moved with the tape — no single reported reason that day.
The brief, in your inbox
One email every market morning. What moved, why, and what happened after.